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Abstract 
This paper has reviewed researches that obtained from peer-reviewed literatures on Salmonellosis and 
Shigellosis. Foodborne diseases related to unhygienic food handling practices remain a major public health 
problem across the globe. The problem is severe in developing countries due to limitations in securing optimal 
hygienic food handling practices. Data shows that an estimated 70% of cases of diarrheal diseases are associated 
with the consumption of foods contaminated with pathogenic microorganisms.  Among these microorganisms 
Salmonella and Shigella are the major ones. In this review, it is noted that these potentially pathogens are still 
public health problems. Therefore, there needs to be frequent monitory and evaluation system so as to plan 
intervention strategies for at risk population in the area of water sanitation and hygienic food handling practice to 
minimize the burden posed by the diseases associated with Salmonellosis and  Shigellosis.         
Keywords: Diarrheal diseases; Foodborne diseases; Salmonellosis; Shigellosis.         
 
Introduction   
Food borne diseases remain a major public health problem across the globe. The problem is severe in developing 
countries due to difficulties in securing optimal hygienic food handling practices. In developing countries, up to 
an estimated 70% of cases of diarrheal disease are associated with the consumption of contaminated food (Zeru 
and Kumie, 2007). Transmission of enteropathogenic bacteria is affected directly or indirectly through objects 
contaminated with faeces. These include food and water indicating the importance of faecal-oral human-to-
human transmission (Gashaw et al., 2008).  
Acute infective diarrhoea and gastroenteritis are major causes of ill health and premature deaths in 
developing world due, in large part, to the lack of safe drinking water, sanitation and hygiene, as well as poorer 
overall health and nutritional status. According to the latest available figures, an estimated 2.5 billion people lack 
improved sanitation facilities, and nearly one billion people do not have access to safe drinking water. These 
unsanitary environments allow diarrhea causing pathogens to spread more easily (UNICEF, 2009). Ranging from 
mild annoyances during vacations to devastating dehydrating illnesses that can kill within hours, acute 
gastrointestinal illnesses rank second only to acute upper respiratory illnesses as the most common diseases 
worldwide. In children <5 years old, attack rates range from 2–3 illnesses per child per year in developed 
countries to as high as 10–18 illnesses per child per year in developing countries (Kasper et al., 2005). 
Diarrhoea is one of the most common childhood illnesses, in both developing and developed countries. 
Estimation by World Health Organization WHO indicates that the world population 
suffered from 4.6 billion incidences of diarrhea causing 2.2 million deaths in the year 2004. While the 
disease is rarely a cause of death in developed countries, it is estimated that approximately 1.6 million children 
die each year from diarrhoea in the developing world. Africa and South Asia are home to more than 80 percent 
of child deaths due to diarrhoea. In addition, by contributing to malnutrition and thereby reducing resistance to 
other infectious agents, gastrointestinal illnesses may be indirect factors in a far greater burden of 
disease(UNICEF,  2009 and WHO, 2004). 
All over the world, severe acute bacterial gastroenteritis is caused mainly by Shigella, whereas 
Salmonella, E. coli (chiefly enteropathogenic E. coli, or EPEC, but also enterohemorrhagic  
E. coli or EHEC, enteroinvasive E. coli or EIEC and other types), Campylobacter and Vibrio spp. have 
been shown to play a role in the epidemiology of diarrhea, especially in certain areas of the globe (Diniz-Santos 
et al., 2005).  
Bacillary dysentery was first differentiated from amoebic dysentery in 1887 and an etiologic agent, 
Bacillus dysenteriae, was isolated and described by Shiga in 1898. Shigella flexneri was originally described by 
Flexner in 1900. Shigella sonnei was first isolated in 1904, but it was not until 1915 that its pathogenic potential 
was recognized by Sonne (Gillespie and Hawkey, 2006). The subsequent painstaking process of epidemiological, 
physiological, and serological characterization of related dysentery bacilli culminated with the recommendations 
of the 1950. Congress of the International Association of Microbiologists Shigella Commission that Shigella be 
adopted as the generic name and that species subgroups be designated A (Shigella dysenteriae), B (S. flexneri), C 
(S. boydii), and D (S. sonnei) (Hale, 1991). 
Bacteria of the genus Salmonella are widespread and important causes of foodborne infections in man, 
and are the most frequent etiologic bacterial agents of foodborne disease outbreaks. According to the latest 
nomenclature, which reflects recent advances in taxonomy (Grimont and Weill, 2007), the genus Salmonella 
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consists of only two major species: S. enterica and S. bongori. Serotypes Typhi (S. Typhi), S. Paratyphi  are 
highly adapted to man. S. Typhi and S. Paratyphi have humans as their main reservoir, and enteric fever (typhoid 
and paratyphoid fever) as their most important clinical manifestation. Enteric fever continues to be an important 
cause of morbidity and mortality in developing countries. Although primarily intestinal bacteria, salmonellae are 
widespread in the environment and commonly found in farm effluents, human sewage and in any material 
subject to faecal contamination. Typhoid fever is a life threatening illness caused by the bacterium Salmonella 
typhi, and was observed by Karl J. Eberth (1880) in the mesenteric nodes and spleen of fatal cases of typhoid 
fever. 
Operational Definition 
Shigellosis and Salmonellosis 
Shigellosis is an acute invasive enteric infection caused by bacteria belonging to the genus Shigella; it is 
clinically manifested by diarrhea that is frequently bloody. Shigellosis is endemic in many developing countries 
and also occurs in epidemics causing considerable morbidity and mortality. Among the four species of Shigella, 
Shigella dysenteriae type 1 (Sd1) is especially important because it causes the most severe disease and may occur 
in large regional epidemics. Major obstacles to the control of shigellosis include the ease with which Shigella 
spreads from person to person and the rapidity with which it develops antimicrobial resistance (WHO, 2005). 
Salmonellosis is an infectious disease of humans and animals caused by organisms of the two species 
of Salmonella; Salmonella enteric and S. bongori (Grimont and Weill, 2007). Clinical syndromes caused by 
Salmonella infection in humans are divided into typhoid fever, caused by Salmonella typhi and Salmonella 
paratyphi(Gordon, 2008).  
General characteristics of genus Shigella and Salmonella 
The cells of the Shigella species are Gram-negative bacilli , nonmotile, non-spore-forming, facultative anaerobic 
rods(Feng,2003) Shigellae are differentiated from the closely related Escherichia coli on the basis of 
pathogenicity, physiology (failure to ferment lactose or decarboxylate lysine) and serology. They are generally 
catalase positive and oxidase and lactose negative. They ferment sugars, usually without forming gas. The strains 
grow between 7 and 46
0
C, with an optimum at 37
0
C and and pH 4.5.  The genus is divided into four serogroups 
with over 2,500 identified multiple serotypes (Thomas and Gerald, 2000). 
Salmonella species are Gram-negative, flagellated, non-sporeforming, facultative anaerobic bacilli 
characterized by O, H, and Vi antigens belongs to the family Enterobacteriaceae. Currently, there are over 2,500 
identified serotypes of Salmonella (Foley and Lynne, 2008). Salmonella typhi is one of the member and  its 
diagnostic identification can be attained by growth on MacConkey and EMB agars, and the bacteria is strictly 
non-lactose fermenting. Flowers (1988) and D'Aoust(1989) reported that  Salmonellae form gas while growing 
in media containing glucose. They are mesophilic, with optimum growth temperature between 35 and 37
0
C, but 
generally have a growth range of 5 to 46
0
C. They are killed by pasteurization temperature and time, sensitive to 
low pH (4.5 or below), and do not multiply at an Aw of 0.94, especially in combination with a pH of 5.5 and 
below. The cells survive in frozen and dried states for a long time.  
Epidemiology  
Shigellosis is a global human health problem. Annually, there are 165 million cases of shigellosis resulting in 1.1 
million deaths in the developing world with high morbidity and mortality (99%) (WHO, 2006 and Michael et al., 
2008). Of these 1.1 million deaths due to Shigella, 69% are in children aged less than five years (Kotloff, 1999 
and WHO, 2006). It is endemic in most developing countries where substandard hygiene and unsafe water 
supplies, in densely populated areas and institutions (Shane et al., 2003 and Gupta 2004). Humans are the only 
natural hosts for  Shigella. The most frequently reported factor associated with the involvement of the infected 
worker was bare hand contact with the food followed by failure to properly wash hands, inadequate cleaning of 
processing or preparation equipment or utensils, cross-contamination of ready-to-eat foods by contaminated raw 
ingredients. In United States and Europe, children in day-care centers, migrant workers, travelers to developing 
countries and individuals in custodial institutions are infected most often (WHO, 2001). 
Salmonellosis is a worldwide health problem. Approximately 95% of cases of human salmonellosis are 
associated with the consumption of contaminated products such as meat, poultry, eggs, milk, seafood, and fresh 
produce (Foley and Lynne, 2008). Risk factors for salmonellosis include gastric hypoacidity, recent use of 
antibiotics, extremes of age, and immunosuppressive conditions (Shelobolina et al., 2004 and Crum-Cianflone, 
2008). With an estimated 16–33 million cases of typhoid fever annually resulting in 216,000 deaths in endemic 
areas, the World Health Organization identifies typhoid as a serious public health problem. Its incidence is 
highest in children and young adults between 5 and 19 years old (WHO.2007).  
Typhoid fever, also called enteric fever,  is a common worldwide  disease, caused by bacterium 
Salmonella typhi, serotype typhi (Giannella,1996). Paratyphoid fever which is caused by S. paratyphi is also a 
systemic disease and its presenting symptoms are similar to those of typhoid fever, but they are milder and the 
case fatality rate is much lower.  S. typhi is a multi-organ pathogen that inhabits the lympathic tissues of the 
small intestine, liver, spleen, and bloodstream of infected humans (WHO, 2003). Today, outbreaks of typhoid 
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fever occur most often in developing countries with poor sanitary systems and lack of antibiotics, in refugee 
camps or in overwhelmed areas with a high population density, putting travelers to Asia, Latin America, and 
Africa in a high risk group. The disease is less common in North America, an estimated 500 cases are reported 
each year in the United States, 70% occurring in travellers returning from endemic areas(Sharma and Sharma, 
1992; USCDCP, 2001 and Lakshmi, 2006).Typhoid fever is more common in children and young adults than in 
olders(Threlfall and  Ward, 2001). Typhoid fever is a disease occurring more commonly among people after 
travel to, or residence in, developing countries where sanitation is poor and where there is faecal contamination 
of food and water (Edelman and Levine, 1986).   
The morbidity of typhoid fever is more severe among infected patients with immune suppression, 
biliary and urinary tract abnormalities and the like (Cohen, et al., 1987). The mortality with severe typhoid fever 
is up to 32% depending on the country studied (Hoffman, et.al, 1984; WHO,2007). 
Microbiology, Mode of spread and Virulence factors  
There are four Shigellae species (serogroups) are defined on the basis of serologic or biochemical reactions, 
namely, Shigella dysenteriae, serogroup A; Shigella flexneri, serogroup B; Shigella boydii, serogroup C; and 
Shigella sonnei, serogroup D that cause shigellosis, and all but S. sonnei have more than one genetically distinct 
subtype (serotype) (von Seidlein, 2006).  
Several studies showed that species classification has important therapeutic implications because the 
species differ in both geographic distribution and antimicrobial susceptibility (Finkelstein et al. , 2002 and 
Ashkenazi et al. 2003).  
Species Serogroup Serotypes  
S. dysenteriae A 1 – 12 most common, with outbreaks 
S. flexneri B 1 – 6 
(with 15 subtypes) 
 
developing countries 
S. boydii C 1-18  
S. sonnei D 1 developed countries*  
Table 1: Species and serogroups of Shigella (Sourse: Thomas and Gerald, 2000). 
(*Edwards. 1999; Prado, 1999; Ashkenazi  et al. ,1993; Yurdakok et al.,1997and Kotloff, 1999). 
Shigellosis is initiated by ingestion of shigellae  usually via fecal-oral contamination, via direct person 
to- person contact, and via food, water, and inanimate objects (WHO, 2001). Only a small number of ingested 
bacteria are required to produce illness. An early symptom, diarrhea (possibly elicited by enterotoxins and/or 
cytotoxin), may occur as the organisms pass through the small intestine. The hallmarks of shigellosis are 
bacterial invasion of the colonic epithelium and inflammatory colitis. These are interdependent processes 
amplified by local release of cytokines and by the infiltration of inflammatory elements. Colitis in the 
rectosigmoid mucosa, with concomitant malabsorption, results in the characteristic sign of bacillary dysentery: 
scanty, unformed stools tinged with blood and mucus. The disease is communicable as long as an infected 
person excretes the organism in the stool, which can extend up to four weeks from the onset of illness. 
Secondary attack rates, the number of exposed persons developing the disease within one to four days following 
exposure to the primary case (Park, 2005), can be as high as 40% among household contacts (Sur,2004). Flies 
especially Musca domestica, are also considered to play an important role in the spread of Shigella (Dupont et al., 
1989). 
Shigella dysenteriae type 1 produces severe disease and may be associated with life-threatening 
complications. Shiga toxin, encoded chromosomally and found mainly in S. dysenteriae serotype 1, is a potent 
protein-synthesis inhibitor that targets primarily the vascular endothelium (Sandvig, 2001; Thorpe, 2001 and 
Bitzan and te Loo, 2003). Shiga toxin mediates the severe complication of hemolytic-uremic syndrome (Ray and  
Liu, 2001 and Bitzan and te Loo, 2003). In addition, Shiga toxin might play a role in the increased duration and 
severity of the diarrhea caused by S. dysenteriae serotype 1 (Faruque et al., 1998 and Edwards, 1999). Moreover, 
Shigella enterotoxin 1 (ShET1) and ShET2, which are produced by several Shigella strains, were also found to 
induce fluid secretion into the intestine, thus accounting for the watery phase of diarrhea (Schroeder and Hilbi, 
2008). 
Virulence genes of this organism are coded on both chromosomes and plasmids. The severe irritation 
that is responsible for the bloody diarrhea is caused partly by LPS in its outer membrane, as well as a Shiga 
Toxin (an A-B toxin), produced by this organism, which acts as a cytotoxin, causing cell necrosis and ulceration, 
(Acheson, 1991 and Yavzori et al., 2002). The Shiga toxins work by inhibiting protein synthesis in the host cells 
and cause cell death. After entering a cell, the Shiga toxin acts as an N-glycosidase, cleaving several nucleobases 
from the RNA that comprises the ribosome, thereby halting protein synthesis ( Dutta et al., 2004). 
Pathogenesis  
Shigellosis is an acute invasive enteric infection and it is clinically manifested by diarrhoea that is frequently 
mucoid or  bloody and can lead to death. It is a disease limited to humans and certain other primates (Pozsgay, et 
al, 2006 and Phalipon  and Sansonetti ,2007). Shigellosis is highly communicable of the bacterial diarrheas. 
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Experiments in volunteers have demonstrated that shigellosis is unique among bacterial enteropathogens in that 
fewer than 200 viable cells can readily produce the disease in healthy adults. The reasons for this low-dose 
response are not completely clear. One possible explanation is that virulent Shigella can withstand the low pH of 
gastric juice therefore gastric acids will have little effect on destroying them (Smith, 1987 and Flowers,1988). 
Shigella infections are almost always limited to the gastrointestinal tract; bloodstream invasion is quite rare 
(Jawetz et al., 2003 and Mandell et al., 2005). 
Shigella causes disease by invading and replicating in cells lining the colonic mucosa. Structural gene 
proteins mediate the adherence of the organisms to the cells, as well as their invasion, intracellular replication, 
and cell-to-cell spread. Shigella species appear unable to attach to differentiated mucosal cells; rather, they first 
attach to and invade the M cells located in Peyer's patches. Then, secretion of proteins into epithelial cells and 
macrophages is mediated. These proteins induce membrane ruffling on the target cell, leading to engulfment of 
the bacteria. Shigella lyse the phagocytic vacuole and replicate in the host cell cytoplasm. With the 
rearrangement of actin filaments in the host cells, the bacteria are propelled through the cytoplasm to adjacent 
cells, where cell-to-cell passage occurs. In this way, Shigella organisms are protected from immune-mediated 
clearance. Shigellae survive phagocytosis by inducing programmed cell death (apoptosis). This process this in 
turn destabilizes the integrity of the intestinal wall and allows the bacteria to reach the deeper epithelial cells 
(Murray et al., 2005). Following host epithelial cell invasion and penetration of the colonic mucosa, Shigella 
infection is characterized by degeneration of the epithelium and inflammation of the lamina propria. This results 
in desquamation and ulceration of the mucosa, and subsequent leakage of blood, inflammatory elements and 
mucus into the intestinal lumen. Patients suffering from Shigella infection will therefore pass frequent, scanty, 
dysenteric stool mixed with blood and mucus, since, under these conditions, the absorption of water by the colon 
is inhibited (Todar, 2009).  
According to WHO (2005), S. dysenteriae type 1 differs from other Shigella in four important ways: 
  it produces a potent cytotoxin (Shiga toxin); 
  it causes illness that is more severe, more prolonged, and more frequently fatal than is illness caused by 
other Shigella; 
  resistance to antimicrobials occurs more frequently than among other Shigella; and 
  it causes large, often regional, epidemics, frequently with high attack rates and high case fatality rates. 
Salmonella typhi has a combination of characteristics that make it an effective pathogen. This species 
contains an endotoxin typical of Gram negative organisms, as well as the Vi antigen which is thought to increase 
virulence. It also produces and excretes a protein known as “invasin” that allows non-phagocytic cells to take up 
the bacterium, where it is able to live and replicate intracellularly. It is also able to inhibit the oxidative burst of 
leukocytes, making innate immune response ineffective. 
Human beings become infected with S .typhi through ingestion of faecal contaminated food, milk, or 
water. 1–5% of infected people become chronic carriers by harbouring S. typhi in the gall bladder, despite 
antibiotic therapy (WHO, 2003). The inoculum size and the type of vehicle in which the organisms are ingested 
greatly influence both the attack rate and the incubation period.  Epidemiological data suggest that waterborne 
transmission of S. typhi usually involves small inocula, whereas foodborne transmission is associated with large 
inocula and high attack rates over short periods. For foodborne salmonellosis, an individual generally has to 
consume ca. 10
5–6 
cells; however, for some virulent strains, ingestion of fewer cells can cause the disease. Strains 
sensitive to gastric acidity generally need more cells to establish in the intestine and cause the disease; 
conversely, acidresistant strains may require fewer cells to cause the disease.   
Depending on the size of the inoculum ingested and the health and immune status of the person, the 
incubation period of S. typhi ranges from 5 to 21 days. In volunteers who ingested 10
9 
and 10
8
 pathogenic S. 
typhi in 45 ml of skimmed milk, clinical illness appeared in 98% and 89% respectively. Doses of 10
5
 caused 
typhoid fever in 28% to 55% of volunteers, whereas none of 14 persons who ingested 10
3
 organisms developed 
clinical illness. (Hornick,et al., 1970;  Pearson and Guerrant, 2000).  
Pathogenic salmonellae ingested in food can survive passage through the gastric acid barrier and 
invade the mucosa of the small and large intestine and produce toxins. Invasion of epithelial cells stimulates the 
release of pro-inflammatory cytokines which induce an inflammatory reaction. The acute inflammatory response 
causes diarrhea and may lead to ulceration and destruction of the mucosa. The bacteria can disseminate from the 
intestines to cause systemic disease. According to Rodriguez et al. (1986) and MacLennan et al. (2004), the 
pathogenesis of enteric fever depends on the ingested inoculum size of S typhi, the virulence of the strain such as 
possession of a complete lipopolysaccharide coat, the presence of the Vi antigen, and the production and 
excretion of a protein (invasion), the host’s immune response and previous exposure, and local protective factors. 
Numerous extra-intestinal complications can occur with S typhi infection, including the involvement of the 
central nervous system (3–35%), cardiovascular system (1–5%), pulmonary system (1–86%), bone and joints 
(1%), hepatobiliary system (1–26%), genitourinary system (<1%), and others (Pearson and Guerrant, 2000 and 
Su, et al., 2004). Study by Threlfall  and Ward (2001) showed that a chronic carrier state is established in an 
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estimated 1 -5% of cases.  
Garcia-del Portillo, et al. (1993) and Foster (1993) showed that once ingested, S .typhi is able to 
survive exposure to gastric acid in the stomach before passage into the small intestine. S .typhi possess a two-
stage inducible acid tolerance system that allows the bacterium to survive in conditions of severe low pH stress 
(pH 3·3). The first stage involves the production of an inducible pH homeostasis system functional at external 
pH values below 4·0, and the second stage involves the synthesis of acid shock proteins that are essential for pH 
3·3 acid tolerance. 
In the small intestine, S .typhi penetrates the intestinal mucosa via M cells that overlie the ileal 
Peyer’s patches (Kohbata et al., 1986).  S. typhi are then taken up by mononuclear cells in the 
intestinal lymphoid tissue, which may lead to dissemination via the lymphatic system or the haematogenous 
route. This intracellular bacterium multiplies in reticuloendothelial cells and macrophages located in the lymph 
nodes, liver, spleen, and bone marrow during the asymptomatic incubation phase of typhoid fever. Once a 
threshold level of S .typhi is reached, the bacteria are released into the blood, initiating a continuous secondary 
bacteraemia with secretion of cytokines by macrophages during the symptomatic phase of typhoid 
fever(MacLennan et al.,2004). This secondary, and persistent, bacteraemia seeds additional organs, which results 
in extra-intestinal infectious complications. 
Pathogenesis of extra-intestinal infections by S .typhi  
Central nervous system involvement with S .typhi infection occurs in 3–35% of patients. Green and Cheesbrough 
(1993), Dutta et al.(2001) and WHO (2003)  reported that central nervous system manifestations include 
encephalopathy, meningitis (12%), transient Parkinsonism, motor neuron disorders, ataxia, cerebral abscesses, 
cerebral oedema, seizures, and Guillain–Barre syndrome. 
Cardiac problems caused by S .typhi infection, such as myocarditis and endocarditis, occur in 1–5% of 
cases(Schneider et al., 1976; Kamili et al., 1996;  Ghadage and  Bal, 2001; Khan et.al, 2003). Pericarditis and 
arteritis occur in less than 1% of cases. Most patients with cardiac infectious complications have underlying 
cardiac abnormalities such as existing valvular abnormalities, rheumatic heart disease, or congenital heart defects. 
Respiratory symptoms of typhoid fever, such as cough, occur in 11–86% of cases. Studies by Dutta et al. (2001) 
and Su  et al. (2004) indicated patients with pulmonary manifestations of typhoid fever often have underlying 
lung abnormalities, a previous history of lung infection, sickle cell anemia, alcohol abuse, diabetes, or 
immunosuppression with HIV/AIDS. Patients may present with fever, chills, cough (with or without productive 
sputum), pleuritic pain, coarse crackles and bronchial breathing on auscultation, diarrhoea, and leucopenia. 
Organ system 
involved 
Prevalence Risk factors Complications 
Central nervous 
system  
3–35% Residence in endemic region, malignancy, 
endocarditis, congenital heart disease, 
paranasal sinus infections, pulmonary 
infections, meningitis, trauma, surgery, and 
osteomyelitis of the skull 
Encephalopathy, cerebral oedema, subdural 
empyema, cerebral abscess, meningitis, 
ventriculitis, transient Parkinsonism, motor 
neuron disorders, ataxia, seizures, Guillain–
Barre syndrome, psychosis 
Cardiovascular 
system 
1–5% Cardiac abnormalities, eg. existing valvular 
abnormalities, rheumatic heart disease, or 
congenital heart defects 
Endocarditis, myocarditis, pericarditis, arteritis, 
congestive heart failure 
Pulmonary 
system 
1–6% Residence in endemic region, past pulmonary 
infection, sickle cell anaemia, alcohol abuse, 
diabetes, HIV infection 
Pneumonia, empyema, bronchopleural fistula 
Bone and joint <1% Sickle cell anaemia, diabetes, systemic lupus 
erythematosus, lymphoma, liver disease, 
previous surgery or trauma, those at extremes 
of age, and 
steroid use 
Osteomyelitis, septic arthritis 
Hepatobiliary 
system 
1–26% Residence in endemic region, pyogenic 
infections, intravenous drug use, splenic 
trauma, HIV, haemoglobinopathy 
Cholecystitis, hepatitis,hepatic abscesses, 
splenic abscess, peritonitis, paralytic ileus 
Genitourinary 
system 
<1% Urinary tract, pelvic pathology, and systemic 
abnormalities 
Urinary tract infection, renal abscess, pelvic 
infections, testicular abscess, 
prostatitis, epididymitis 
Soft tissue 
infections 
least cases 
reported  
Diabetes Psoas abscess, gluteal abscess, cutaneous 
vasculitis 
Haematological least cases 
reported  
 Haemophagocytosis syndrome 
Table 2: Extra-intestinal infectious complications of typhoid fever caused by Salmonella enterica serotype Typhi 
(Source: Su  et al. 2004) 
Toxins 
Following ingestion of Salmonella cells, the pathogens invade mucosa of the small intestine, proliferate in the 
epithelial cells, and produce a toxin, resulting in an inflammatory reaction and fluid accumulation in the intestine. 
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The ability of the pathogens to invade and damage the cells is attributed to the production of a thermostable 
cytotoxic factor. Once inside the epithelial cells, the pathogens multiply and produce a thermolabile enterotoxin 
that is directly related to the secretion of fluid and electrolytes. Production of the enterotoxin is directly related to 
the growth rate of the pathogens(Hornick et al.,1970; Pearson and Guerrant, 2000). 
 
Figure: 1. The lifestyle of Salmonella typhi in the human host and implications for diagnostics. (Source: Baker, 
BMC Infectious Diseases, 2010).  
A: For S. typhi infection, the organism normally enters the human host through oral ingestion of an infectious 
dose.  
B: S. typhi does not replicate in large numbers in the intestine and shedding may be sporadic and limited.  
C:  Invasion occurs through the terminal ileum, perhaps a short time after ingestion, M cells may be the 
preferred portal of entry.  
D: S. typhi is transferred to monocytic cells and is trafficked to the reticulo-endothelial system, potentially in a 
semi-dormant state.  
E: S. typhi re-emerges at an unknown time from the reticulo-endothelial system, possibly as the acquired 
immune response is activated, and re-enters the blood stream in low numbers.  
F: S. typhi seeds into the liver, the gall bladder and the bone marrow where it can reside and may be detected for 
months or years.  
G: S. typhi can enter into the bile duct and be shed sporadically, potentially in high numbers into the 
environment via the intestine.  
Clinical features 
Shigellosis typically evolves through several phases and manifestations of Shigella infection vary with the 
infecting species, the age of the host, the presence of risk factors and the specific immune status of the host. 
Clinical presentations of shigellosis are watery diarrhea occurring in younger children and associated with a 
shorter duration of illness and with more vomiting and dehydration and dysentery with stool blood and 
abdominal pain. These different presentations may reflect two mechanisms in the pathogenesis of shigellosis or 
different stages of the disease. The most useful signs and symptoms for the diagnosis of shigellosis were stool 
with blood and abdominal pain in all patients and the absence of watery diarrhea and vomiting in patients over 
one year old. Simple visual inspection of stool for blood correctly identified 44% of all patients infected with 
Shigella (Stoll et al., 1982). 
The incubation period is 1 to 4 days, but may be as long as 8 days with S. dysenteriae (Levine et al., 
1973). The clinical manifestation of shigellosis ranges from an asymptomatic illness to bacteraemia and sepsis. 
Symptoms include fever, diarrhoea and/or dysentery with abdominal cramps and ineffectual and painful 
straining at stool or in urinating (Niyogi, 2005). Shigellosis may be associated with mild to life-threatening 
complications, such as rectal prolapse, arthralgia (painful joints), arthritis, intestinal perforation, and toxic mega 
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colon (extreme inflammation and distension of the colon), central nervous disorders, convulsions, enteropathy 
(protein-losing disease of the intestines), electrolyte imbalance of salts, and sepsis (Ozuah, 1998; Sur, 2004 and 
WHO2005b). Haemolytic uraemic syndrome (a complication resulting in kidney failure, bleeding, and anaemia) 
and leukemoid reaction (blood findings resembling leukaemia) complicate infection due to S. dysenteriae type 1 
and may be fatal.  
Diagnosis 
The most useful signs and symptoms for the diagnosis of shigellosis are stool with blood and abdominal pain in 
all patients and the absence of watery diarrhea and vomiting in patients over one year old (Stoll et al., 1982). 
Routine microscopy of fresh stool is a simple screening test that is cheap, rapid, and easy to perform; and 
visualization of numerous poly-morphonucleocytes suggests a bacterial  aetiology. Definite diagnosis of 
shigellosis can only be made by stool culture (WHO, 2005a). However, Shigella species die rapidly in 
unfavourable environments and stool culture should ideally be supplemented by attempts to identify Shigella 
DNA using polymerase chain reaction (PCR) (von Seidlein 2006). 
The definitive diagnosis of typhoid fever depends on the isolation of S. typhi from blood, bone marrow 
or a specific anatomical lesion. (Benavente et al., 1984; Vallenas et al., 1985 and Wain et al., 2001) The 
presence of clinical symptoms characteristic of typhoid fever or the detection of a specific antibody response is 
suggestive of typhoid fever but not definitive. Blood culture is the mainstay of the diagnosis of this disease. 
Additionally, the presence of Salmonella typhi  can be  detected either by the demonstration of specific 
antibodies or antigen in the serum or urine. The organism may be cultured from stool or urine (Giannella, 1996 
and  US,1980). 
Prevention and Treatment 
The most effective methods for controlling shigellosis are provision of safe and abundant water and effective 
faeces disposal. Prevention of dysentery caused by Shigella relies primarily on measures that prevent spread of 
the organism within the community and from person to person (WHO/CDR/95.4). These include: 
  hand-washing with soap, 
  ensuring the availability of safe drinking water, 
 safely disposing of human waste, 
 breastfeeding of infants and young children, 
  safe handling and processing of food, and 
  control of flies. 
These measures will not only reduce the incidence of shigellosis, but of other diarrhoeal diseases as well. In all 
cases, health education and the cooperation of the community in implementing control measures are essential. 
In general,  several studies and Edwards (1999),  reported  that the most effective intervention strategy to 
minimize morbidity and mortality would involve comprehensive media and personal outreach programs 
consisting of the following components: 
 Education of all residents to actively avoid faecal contamination of food and water and to encourage 
hand washing after defecation; 
 Encourage mother to breast feed infants; 
 Promote the use of oral rehydration therapy to offset the effects of acute diarrhea; 
 Encourage mothers to provide convalescent nutritional care in the form of extra food for children 
recovering from diarrhea or dysentery. 
The key to avoiding infection by S. typhi is prevention of fecal contamination in drinking water and food 
supplies. Since the only source of this agent is infected humans, it is possible to control transmission by proper 
hygiene, waste management, water purification, and treatment of the sick. Health education is paramount to raise 
public awareness and induce behaviour change. 
Vaccination 
The old parenteral killed whole-cell vaccine was effective but produced strong side-effects because of LPS.  
Yang  et al. (2001) revealed that two safe and effective vaccines are now licensed and available. One is based on 
defined subunit antigens (Vi polysaccharide, is given in a single dose Subcutaneous), the other on whole-cell live 
attenuated bacteria (the live oral vaccine Ty2la, available in enteric-coated capsule or liquid formulation (Lin et 
al., 2001). Vaccination against typhoid fever before or during an outbreak situation should therefore be seriously 
considered as an effective tool. 
Fluids &Nutrition and Antimicrobial Therapy 
The mainstay of treatment of shigellosis in children is correction of the fluid and electrolyte loss, which often 
can be achieved by administering oral rehydration solutions (Edwards, 1999,  Khan  et al. 1999). Early feeding, 
even with a high-protein diet, is important, especially in developing countries, to prevent malnutrition and 
encourage optimal growth (Kabir et al. 1998). Rehydration therapy is an essential first step which can be used to 
correct dehydration due to diarrheas of any etiology and has greatly decreased the number of deaths due to 
diarrhoea.  
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Various antimicrobial agents are effective in the treatment of shigellosis, although options are becoming limited 
because of globally emerging drug resistance (Ashkenazi ,2002; Bhattacharya and  Sur, 2003). Resistance of 
Shigella species to sulfonamides, tetracyclines, ampicillin, and trimethoprim-sulfamethoxazole (TMP-SMX) has 
been reported worldwide and these agents are not recommended as empirical therapy unless local microbiologic 
data suggest susceptibility (Ashkenazi et al., 2003).  
The World Health Organization recommends that all suspected cases of shigellosis based on clinical 
features be treated with effective antimicrobials (antibiotics) (WHO, 2006 and Christopher et al., 2010).
  
According to the WHO guidelines (WHO/CDR/95.3), the choice of antimicrobial drug has changed over the 
years as resistance to antibiotics has occurred, with different patterns of resistance being reported around the 
world. Evidence is insufficient to consider any class of antibiotic superior in efficacy in treating Shigella 
dysentery.  
The following antibiotics are used to treat Shigella dysentery: 
• Beta-lactams: Ampicillin, amoxicillin, third-generation cephalosporins (cefixime, ceftriaxone), and 
pivmecillinam (not available in the United States)  
• Quinolones: Nalidixic acid, ciprofloxacin, norfloxacin, and ofloxacin 
• Macrolides: Azithromycin 
• Others: sulfonamides, tetracycline, cotrimoxazole, and furazolidone. 
The oral rehydration therapy is a simple way to prevent many of the deaths of diarrheal diseases in 
general. Supportive measures such as appropriate nutrition and blood transfusions are also important in the 
management of typhoid fever if indicated. More than 90% of patients can be managed at home with oral 
antibiotics, reliable care and close medical follow-up for complications or failure to respond to therapy (Punjabi, 
2000). Where resistance is uncommon, the treatment of choice is a fluoroquinolones such as ciprofloxacin 
(Chinh et al., 2000; Parry and Beeching, 2009 and Effa et al. ,2011). The fluoroquinolones attain excellent tissue 
penetration, kill S. typhi in its intracellular stationary stage in monocytes/macrophages and achieve higher active 
drug levels in the gall bladder than other drugs.  Otherwise, a third-generation cephalosporin such as ceftriaxone 
or cefotaxime is the first choice (Soe  and Overturf ,1987; Wallace  et al.,1993 and Dutta et al., 2001). Cefixime 
is a suitable oral alternative (Bhutta et al., 1994 and Cao et al.,1999).  
However, the emergence of MDR strains has reduced the choice of antibiotics in many areas. There 
are two categories of drug resistance: resistance to antibiotics such as chloramphenicol, ampicillin and 
trimethoprim-sulfamethoxazole/ TMP-SMZ (MDR strains) and resistance to the fluoroquinolone drugs. 
Resistance to the fluoroquinolones may be total or partial (Das  et al., 2000;  Gupta  et.al, 2001;  Dutta et al., 
2001 and Cooke et al., 2006).  
When untreated, typhoid fever persists for three weeks to a month. Death occurs in between 10% and 
30% of untreated cases (WHO, 2007). 
 Optimal therauphy  Alternative effective drugs 
Susceptibility Antibiotic  Daily 
dose 
mg/kg 
Days Antibiotic  Daily dose 
mg/kg 
Days 
Fully sensitive  Fluoroquinolones 
Eg. Ofloxacin or  
ciprofloxacin 
15 
 
5-7 Chloramphenicol 
amoxicillin 
TMP-SMZ 
50-75 
75-100 
8-40 
14-21 
14 
14 
Multidrug  
resistance  
Fluoroquinolone or 
cefixime  
15 
15-20 
5-7 
7-14 
Azithromycin 
cefixime 
8-10 
15-20 
7 
7-14 
 
Quinolone 
resistance  
Azithromycin or 
ceftriaxone 
8-10 
75 
7 
10-14 
cefixime 20 7-14 
Table:3.  treatment of typhoid fever (Source: The Indian Journal of Medical Research 2001;113: 210-213.) 
Conclusion  
The epidemiology of Shigella dysenteriae is worldwide and the organism is responsible for bacillary dysentery. 
This disease is most often associated with areas of overcrowding and poor sanitation. Symptoms of dysentery 
due to this organism include mild to severe diarrhea, which is sometimes bloody or watery and the like. The 
organism  penetrate the mucosal epithelial cells of the intestine and penetration causes severe irritation which is 
responsible for the cramps and watery, bloody diarrhea. Dehydration can become a complication. Virulence 
genes of this organism are coded on both chromosomes and plasmids. The severe irritation that is responsible for 
the bloody diarrhea is caused partly by LPS in its outer membrane, as well as a Shiga. The Shiga Toxin causes 
cell death by preventing protein synthesis by cleaving a specific adenine residue from RNA. Definite diagnosis 
of shigellosis can only be made by stool culture and PCR. This organism can be successfully treated with 
antibiotics such as ampicillin and ciprofloxacin. Fluids can be given to those individuals suffering from 
Food Science and Quality Management                                                                                                                                             www.iiste.org 
ISSN 2224-6088 (Paper)  ISSN 2225-0557 (Online) 
Vol.39, 2015 
 
63 
dehydration. Since it is predominantly spread by the fecal-oral route, thoroughly washing hands, proper food 
handling is also an important method of prevention, as well as maintaining clean water supplies, which is highly 
effective.  
Infection caused by S. typhi remains an important public health problem, particularly in developing 
countries. Morbidity and mortality attributable to typhoid fever are once again increasing with the emergence 
and worldwide spread of S. typhi strains that are resistant to most previously useful antibiotics. As a consequence 
there is renewed interest in understanding the epidemiology, diagnosis and treatment of typhoid fever and some 
specific aspects of its pathogenesis. Extra-intestinal infectious complications caused by S. typhi are uncommon. 
However, when S. typhi bacteraemia occurs virtually any organ system may be potentially involved. In general, 
fluorquinolones and third-generation cephalosporins are the first-line therapy for infections with S typhi. 
Alternative therapy for susceptible strains consists of ampicillin, chloramphenicol, and co-trimoxazole. More 
importantly, perhaps, there is much interest in the possibility of expanded roles for typhoid vaccines. Now, 
devise ways of using the two currently available improved typhoid vaccines, parenteral Vi polysaccharide and 
oral Ty21a. 
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